JUNG MIN LEE: Open Payments
NPI 1366193500 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 46 payments from 14 companies in 2025. Trend: 2023 $236 · 2024 $882 · 2025 $889
Food & beverage: $838Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $262 |
| Gilead Sciences, Inc. | 1 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Janssen Biotech, Inc. | 2 | $72 |
| Lilly USA, LLC | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| GENZYME CORPORATION | 2 | $41 |
| Ardelyx, Inc. | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 6 | $30 |
Products named: Livdelzi, RINVOQ, DUPIXENT, ENTYVIO, TREMFYA, OMVOH, CREON, VIBERZI.
Industry payments across GA — which companies pay providers there.
